1stdibs.com, Inc. (DIBS) Dividend History

1stdibs.com, Inc. is an online marketplace specializing in high-end antique, vintage, and modern furniture, jewelry, art, and design objects. Founded in 2001, it connects discerning buyers with a curated network of dealers, galleries, and individual sellers from around the world, offering unique and luxury items for interior design and collection purposes.

300 Park Avenue South, New York, NY, 10010
Phone: 212-627-3929
Website: https://www.1stdibs.com

Dividend History

1stdibs.com, Inc. currently does not pay dividends

Company News

  • 1stdibs.com CFO Thomas J. Etergino sold 4,500 shares of the company's stock at $4.4047 per share, totaling $19,821. Despite the sale, Etergino still holds 111,200 shares, indicating his continued investment in the company's future.

    Investing.com
  • Here is how Casey's General Stores (CASY) and 1stdibs.com (DIBS) have performed compared to their sector so far this year.

    Zacks Investment Research
    Featured Companies: CASY
  • NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) -- 1stdibs.com, Inc. (NASDAQ: DIBS), a leading online marketplace for luxury design products ("1stDibs" or the "Company"), today reported financial results for its first quarter ended March 31, 2024.

    GlobeNewswire Inc.
  • LivePerson's Rob LoCascio helps us see the future.

    The Motley Fool
    Featured Companies: DAL GOOG GOOGL HD LPSN TWLO VZ
  • Upgrades Citigroup upgraded the previous rating for FinVolution Group (NYSE:FINV) from Neutral to Buy. FinVolution Gr earned $0.30 in the first quarter, compared to $0.31 in the year-ago quarter. The stock has a 52-week-high of $10.41 and a 52-week-low of $2.68. At the end of the last trading period, FinVolution Gr closed at $4.21. For Noble Corp (NYSE:NE), BTIG upgraded the previous rating of Neutral to Buy. At the moment, the stock has a 52-week-high of $37.77 and a 52-week-low of $20.34. Noble closed at $36.28 at the end of the last trading period. For Vertex Pharmaceuticals Inc (NASDAQ:VRTX), Maxim Group upgraded the previous rating of Hold to Buy. For the first quarter, Vertex Pharmaceuticals had an EPS of $3.52, compared to year-ago quarter EPS of $2.98. The stock has a 52-week-high of $292.75 and a 52-week-low of $176.36. At the end of the last trading period, Vertex Pharmaceuticals closed at $268.65. For Visteon Corp (NASDAQ:VC), Morgan Stanley upgraded the previous rating of Underweight to Equal-Weight. Visteon earned $1.09 in the first quarter, compared to $0.56 in the year-ago quarter. At the moment, the stock has a 52-week-high of $134.57 and a 52-week-low of $88.82. Visteon closed at $112.21 at the end of the last trading period. For Home Bancorp Inc (NASDAQ:HBCP), DA Davidson upgraded the previous rating of Neutral to Buy. Home Bancorp earned $0.53 in the first quarter, compared to $1.41 in the year-ago quarter. At the moment, the stock has a 52-week-high of $45.73 and a 52-week-low of $33.16. Home Bancorp closed at $34.39 at the end of the last trading period. For Park Hotels & Resorts Inc (NYSE:PK), Truist Securities upgraded the previous rating of Hold to Buy. Park Hotels & Resorts earned $0.08 in the first quarter, compared to $0.48 in the year-ago quarter. At the moment, the stock has a 52-week-high of $22.42 and a 52-week-low of $15.57. Park Hotels & Resorts closed at $18.06 at the end of the last trading period. Cowen & Co. upgraded the previous rating for Xylem Inc (NYSE:XYL) from Underperform to Market Perform. In the first quarter, Xylem showed an EPS of $0.47, compared to $0.56 from the year-ago quarter. At the moment, the stock has a 52-week-high of $138.78 and a 52-week-low of $78.92. Xylem closed at $84.25 at the end of the last trading period. For Blueprint Medicines Corp (NASDAQ:BPMC), Jefferies upgraded the previous rating of Hold to Buy. In the first quarter, Blueprint Medicines showed an EPS of $1.79, compared to $1.72 from the year-ago quarter. At the moment, the stock has a 52-week-high of $117.86 and a 52-week-low of $50.95. Blueprint Medicines closed at $55.00 at the end of the last trading period. RBC Capital upgraded the previous rating for Danaher Corp (NYSE:DHR) from Sector Perform to Outperform. Danaher earned $2.76 in the first quarter, compared to $2.52 in the year-ago quarter. The current stock performance of Danaher shows a 52-week-high of $333.96 and a 52-week-low of $233.71. Moreover, at the end of the last trading period, the closing price was at $263.82. For Enanta Pharmaceuticals Inc (NASDAQ:ENTA), Evercore ISI Group upgraded the previous rating of Underperform to In-Line. In the second quarter, Enanta Pharmaceuticals showed an EPS of $1.63, compared to $1.09 from the year-ago quarter. At the moment, the stock has a 52-week-high of $102.00 and a 52-week-low of $37.59. Enanta Pharmaceuticals closed at $39.93 at the end of the last trading period. For CatchMark Timber Trust Inc (NYSE:CTT), Raymond James upgraded the previous rating of Underperform to Market Perform. CatchMark Timber Trust earned $0.07 in the first quarter, compared to $0.01 in the year-ago quarter. The stock has a 52-week-high of $12.57 and a 52-week-low of $7.18. At the end of the last trading period, CatchMark Timber Trust closed at $11.79. See all analyst ratings upgrades. Downgrades Redburn Partners downgraded the previous rating for Valero Energy Corp (NYSE:VLO) from Buy to Neutral. In the first quarter, Valero Energy showed an EPS of $2.31, compared to $1.73 from the year-ago quarter. The stock has a 52-week-high of $135.75 and a 52-week-low of $58.85. At the end of the last trading period, Valero Energy closed at $129.60. According to UBS, the prior rating for Angel Oak Mortgage Inc (NYSE:AOMR) was changed from Buy to Neutral. Angel Oak Mortgage earned $1.49 in the first quarter, compared ...Full story available on Benzinga.com

    Benzinga
Page data last updated 07/23/2025 16:08:14 UTC